Ketamine Completed Phase 2 Trials for Suicide / Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02094898Ketamine for Depression and Suicide Risk
NCT02106325Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
NCT01880593Ketamine Plus Lithium in Treatment-Resistant Depression